title: Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
abstract: Thymidine kinase 1 (TK1), an enzyme involved in the synthesis of precursors for DNA, and thus proliferation dependent, has been suggested as a good tumour marker. We have recently developed poly/monoclonal antibodies against TK1, which proved useful for diagnostics in both serum and immunohistochemistry of cancer patients. The anti-TK1 monoclonal antibodies (mAbs) 1D11 and 1E3 were characterized by Western blot, immunoprecipitation and flow cytometry. TK1 mAbs and Ki-67 mAb were then used for immunohistochemistry staining of tumour sections from 54 patients with ductal infiltrated breast carcinoma. Results showed the relative number of patients with positively stained tumours for TK1 (mAb 1D11) and for Ki-67 (mAb MIB-1) were 47 and 41%, respectively, significantly related (p=0.007). Combination of TK1 mAbs 1D11 and 1E3 increased this number to 56%, due to detection of a significantly higher number of patients with grade 2 tumours. Patients with stage II and grade 2 tumours showed significantly higher TK1 staining when compared to stage I and grade 1. Ki-67 staining was significantly higher in stage III and grade 3. The tumours only stained for TK1 represented higher stages and grades, while tumours staining only for Ki-67 were of lower stages and grades. Combining TK1 and Ki-67 increased the number of patients with positively stained tumours to 69%. In conclusion, TK1 is a reliable marker for identification of patients with grade 2 tumours. The highest number of patients with positively stained tumours were obtained when both TK1 and Ki-67 markers were used.
authors.affiliation: Department of Oncology Clinical Research Laboratory, Novum, KFC, Karolinska University Hospital, S-141 86 Stockholm, Sweden. qimin.he@medhs.ki.se
authors.forename: Qimin
authors.initials: Q
authors.lastname: He
authors.forename: Yongrong
authors.initials: Y
authors.lastname: Mao
authors.forename: Jainping
authors.initials: J
authors.lastname: Wu
authors.forename: Catrine
authors.initials: C
authors.lastname: Decker
authors.forename: Malik
authors.initials: M
authors.lastname: Merza
authors.forename: Naining
authors.initials: N
authors.lastname: Wang
authors.forename: Staffan
authors.initials: S
authors.lastname: Eriksson
authors.forename: Juan
authors.initials: J
authors.lastname: Castro
authors.forename: Sven
authors.initials: S
authors.lastname: Skog
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000201:enzymology; D003600:Cytosol / Q000201:enzymology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D008875:Middle Aged; D009367:Neoplasm Staging; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D013937:Thymidine Kinase / Q000032:analysis*
chemical_list: D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D013937:Thymidine Kinase; C092717:thymidine kinase 1